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Cost remains a major barrier in accessing effective contraception especially long-acting reversible 
contraception. This study sought to assess the current contraception choices amongst university 
students including the influence of cost on choices. 
 
Methods 
A cross-sectional study of Irish university students at University College Cork was undertaken.  The 
online survey examined current contraception use, justifications for this choice of contraception 
and the effect that hypothetical provision of free contraception would have on their choices.  
 
Results 
A total of 1,840 sexually active students completed the online survey. Condoms were used by 1,020 
students (55.4%), the combined pill was used by 729 (39.6%) and ‘coitus interruptus’ was used by 
169 students (9.1%). Statistically males were more likely to spend under €50 annually (47.6%, n=182 
of 382, p<0.001) and female students were more likely to spend over €100 on contraception (41.2%, 
n=470 of 1,141, p<0.001).By removing cost, 394 (34.3%) sexually active women would definitely 
change contraception, with another 250 women (21.8%) considering changing.  
 
Discussion 
Students often rely on unreliable or user-dependent methods of contraception. Our study has 
demonstrated that cost influences contraceptive choice with nearly half of the women surveyed 
stating they would change contraception if cost was removed.  
Introduction 
In Ireland, currently one in seven pregnancies is perceived as a crisis pregnancy1. With recent 
changes in Irish legislation permitting termination of pregnancy up to twelve weeks gestation2, 
prevention of unplanned pregnancies has received renewed attention. The Citizen’s Assembly on 
the Eighth Amendment raised concerns over the cost of contraception in Ireland and its potential 
prohibitive effects to contraception use3.  
 
Access to contraception is an international problem3, 4, with women aged under 25 are most at risk 
of an unplanned pregnancy, and typically use less reliable forms of contraception1, 5. Difficulty 
accessing contraception increases the likelihood of unprotected sexual intercourse (UPSI)6. Cost was 
cited as a barrier by 17-24 year olds in Ireland to using condoms or the combined oral contraceptive 
pill (COCP)1. Lally et al, highlighted that condoms, the COCP and coitus interruptus were the main 
contraceptives used among Irish students in 20157. Condom use was reported by 89% of the student 
population, however their use was inconsistent, as 69% of students reported recent UPSI7. Non-use 
of contraception remains the leading reason for requiring emergency contraception amongst 
students(8, 9).  
 
The costs associated with long-acting reversible contraceptives (LARCs) affect their uptake10-12.  
LARC uptake has been shown to be inversely proportional to its cost13, once it rises above $200, 
uptake decreases from 87% to 27%10. The CHOICE study highlighted if cost was removed entirely, 
LARC uptake increased to 67%12, with 48% selecting a hormonal intrauterine system 
(Mirena®/Jaydess®/Kyleena®)12. In 2013, Gyllenburg et al demonstrated that it was cost effective to 
provide free LARCs, as the reduction in unplanned pregnancies reduced government expenditure 
on providing terminations.14. LARC uptake was highest among women aged under 25,  evidencing 
their unmet need for contraception14.  
 
Despite several campaigns, students’ use of contraception can be unreliable and inconsistent8, 15. 
The aim of this study was to assess current contraceptive usage amongst students in University 
College Cork (UCC), as well as the factors influencing their choice of contraception, in particular the 




This study was conducted in UCC, which has the second largest full-time undergraduate enrolment 
in the Republic of Ireland16, with nine colleges providing over 120 courses17. In this study, the 
colleges were grouped into; ‘Science, Engineering and Food Science’, ‘Medicine and Health’, ‘Arts, 
Celtic Studies and Social Science’ and ‘Business and Law’. At the time of the study, UCC had 21,894 
undergraduate and postgraduate students16. An online questionnaire was distributed to all students 
with an active UCC email in September 2018 via the UCC email modulator. The email contained 
information regarding the aim of the survey, the data that would be collected plus a link to complete 
the survey using SurveyMonkey®.  
  
 
Contact information of the study co-ordinators was provided in the email and consent to participate 
was obtained by clicking the link to complete the survey. All data was collected anonymously. As an 
incentive, all students who completed the survey were entered into a draw for a €100 One for All® 
voucher to increase the response rate.  
 
The survey consisted of twenty-eight questions divided into three sections. The first section 
collected demographic data including age, relationship status, area of study as well as whether the 
student had previously been sexually active or not. Students who reported previously being sexually 
active were asked if they had been so in the previous six months or not. Data surrounding students’ 
funding of both medical bills and contraceptive costs was collected.  
 
The second section assessed current contraception use, including reasons for their current 
contraceptive choice along with estimated annual contraceptive expenditure.  The list of factors 
influencing contraceptive choices was based on previously published papers(11, 12). Students were 
asked to rank the following factors; ‘cost’, ‘efficacy’, ‘non-contraceptive benefits’, ‘side effects’, 
‘having regular menses’, ‘STI prevention’, ‘availability’, ‘healthcare providers’ opinion’, ‘partner’s 
opinion’, ‘reversibility’, ‘forgettability’, ‘friends/family’s opinion’, ‘not having an irregular period’, 
‘nobody knows you’re using it’. Students were asked if they would change contraceptive if cost was 
removed. The response options included ‘definitely change’, ‘consider changing’ or ‘would not 
change’. If they elected to change, students were asked which of the following they would choose; 
‘combined oral contraceptive’,  ‘Mirena®/Jaydess®’, ‘progesterone only pill’, ‘implant’, 
‘diaphragm/ring’, ‘copper coil’, ‘patch’, ‘depo’ or ‘ a form of long-acting contraception’. This list was 
not exhaustive but contained the most popular long-acting and short-acting contraceptives in use 
in Ireland11. 
 
Ethical approval was obtained from the UCC Clinical Research and Ethical Committee in May 
2018(ECM (4)f 05/06/18). Online responses were collected over a period of a week following the 
distribution of the email containing the study information and survey.  Data analysis was conducted 
using IBM SPSS Version 25®. Descriptive statistical analysis was performed to ascertain the 
demographics of the population that responded. Age was grouped into those aged 18-20, 21-24 and 
those aged over 25. Chi-squared tests were performed to assess the associations with cost, 
reliability, access on the students’ choice. 
 
 
Results   
In total, 2,079 students completed the online survey with 1,840 of them being sexually active, giving 
an overall response rate of 9.5%. Demographic data are outlined in Table 1. The majority of the 
respondents were female (73.7%, n=1,532), and were aged between 18-24 years (79.2%, n=1,664) 
with a relatively even distribution across the different areas of study.  
 
 




Active n (%) 
Never Sexually 
Active (n) 
Gender     
Male 479 (26.2%) 50 (21.6%) 
Female 1348 (73.8%) 182 (78.4%) 
   
Age in years   
Under 18 0 (0%) 1 (0.4%) 
18-20 627 (34.2%) 127 (53.6%) 
21-24 818 (44.7%) 90 (37.9%) 
Over 25 388 (21.2%) 19 (1.1%) 
   
Relationship Status    
In a relationship 1,042 (56.8%) 22 (9.3%) 
Single  794 (43.2%) 215 (90.7%) 
   
Area of Studying    
Science & Engineering 527 (28.7%) 71 (29.9%) 
Medicine & Health 452 (24.6%) 71 (29.9%) 
Arts, Celtic Studies & 
Social Sciences 
528 (28.7%) 64 (27%) 
Business & Law 332 (18%) 31 (13.2%) 
   
Type of Degree   
Undergraduate 1,432 (77.9%) 213 (89.9%) 
Diploma 42 (2.3%) 0 (0%) 
Apprenticeship 0 (0%) 1 (0.4%) 
Masters 227 (12.3%) 15 (6.3%) 
PhD 113 (6.1%) 6 (2.5%) 




Students were asked to select all forms of contraception they currently used. Contraceptive choice 
among sexually active students based on age, gender and relationship status is demonstrated in 
Table 2, with the diaphragm, patch, Depo-Provera® and sterilisation grouped under ‘other 
contraception’. The main contraceptives used by sexually active students (n=1840), in order of 
popularity, were; condoms (55.4%, n=1,020), the COCP (39.6%, n=729) and coitus interruptus (9.1%, 
n=168). The use of LARCs (Implanon®/Copper Coil®/IUS (Mirena®/Jaydess®)) was low, only being used 
by 11.5% (n=213) of sexually active students. Emergency contraception was used by 4.4% (n=81) as 
contraception.  
 
Table 2: Contraceptive Choices based on age, gender and relationship status (*= p<0.05). 
 
 Overall n (%) Age n (%) Relationship Status n (%) Gender n (%) 
  18-20 21-24 Over 25 In relationship Single Male Female 
COCP 729 (39.6) 259 (35.8) 342 (47.2) 123 (17) 458 (63.0)* 269 (37.0)* 143 (19.8)* 581 (80.2)* 
Condoms 1020 (55.4) 388 (38.2) 452 (44.5) 175 (17.2) 508 (49.8)* 512 (50.2)* 302 (29.8)* 712 (52.8)* 
POP 108 (5.9) 37 (34.3)* 58 (53.7)* 13 (12.0)* 54 (50.0) 54 (50.0) 21 (19.6) 86 (80.4) 
Coitus 
Interruptus 
168 (9.1) 59 (35.1) 75 (44.6) 34 (20.2) 114 (67.9)* 54 (32.1)* 49 (29.2) 11 (70.8) 
Implanon 125 (6.8) 48 (0.7) 58 (0.1) 19 (0.9) 73 (58.4) 52 (41.6) 22 (17.6)* 103 (82.4)* 
IUS 58 (3.2) 10 (17.2)* 27 (46.6)* 21 (36.2)* 41 (70.7)* 17 (29.3)* 8 (14.0)* 49 (86.0)* 
Copper Coil 30 (1.6) 4 (13.3)* 14 (46.7)* 12 (40.0)* 20 (71.4) 8 (28.6) 9 (30.0) 21 (70.0) 
Other 
contraception 
38 (2.1) 8 (21.0) 10 (26.3) 20 (52.7) 30 (78.9) 8(21.1) 8 (21.1) 30 (78.9) 
Cyclical Method 41 (2.2) 10 (24.4) 17 (41.5) 14 (34.1) 28 (68.3) 13 (31.7) 12 (30.0) 28 (70.0) 
Emergency 
Contraception 
81 (4.4) 27 (33.3) 41 (50.6) 13 (16.0) 33 (40.7)* 48 (59.3)* 23 (28.7) 57 (71.3) 
Unsure of which 
method 
16 (0.9) 5 (31.3) 5 (31.3) 6 (37.5) 6 (37.5) 10 (62.5) 11(68.8)* 5 (31.3)* 
No 
Contraception 
80 (4.3) 29 (36.3)* 23 (28.7)* 28 (35.0)* 37 (46.3) 43 (53.8) 29 (36.7)* 50 (63.3)* 
 
 
Relationship status influenced the contraception used, with LARCs used more by those in 
relationships (63.3%, n=142 versus 36.3%, n=81). Students in relationships were also statistically 
more likely to use coitus interruptus as their method of ‘contraception’ (67.9%, n=114 versus 32.1%, 
n=54; p<0.001). Condoms were more popular among single students (50.2%, n=512 versus 49.8%, 
n=508; p<0.001), as was emergency contraception (59.3%, n=48 versus 40.7%, n=33; p<0.001). 
Using no contraception was relatively evenly distributed between those in a relationship versus 








Table 3: Reasons for using contraception. 
 
               Reasons    
 
 
Stop Pregnancy n (%) p Value Delay pregnancy  
n (%) 
p value Protect against 
STIs n (%) 
p value 
COCP (n=729) 514 (70.5%) <0.001 233 (32%) <0.001 270 (37%) <0.001 
Condoms (n=1020) 742 (72.7%) <0.001 267 (26.2%) <0.001 572 (56.1%) <0.001 
IUS (n=58) 39 (67.2%) 0.12 15 (25.9%) 0.58 8 (13.8%) <0.001 
Implanon (n=125) 88 (70.4%) 0.02 44 (35.2%) 0.02 34 (27.2%) 0.19 
Copper Coil (n=30) 24 (80%) 0.01 8 (26.7%) 0.62 8 (26.7%) 0.45 
Cyclical Method (n=41) 28 (68.3%) 0.15 9 (22%) 0.88 21 (51.2%) <0.001 
Coitus interruptus 
(n=168) 
118 (70.2%) <0.001 52 (31%) <0.001 68 (40.5%) 0.02 
No contraception (n=83) 23 (27.7%) <0.001 6 (7.2%) <0.001 25 (30.1%) 0.64 
Emergency contraception 
(n=81) 
61 (75.3%) <0.001 22 (27.2%) 0.34 48 (59.3%) <0.001 
 
 
Table 3 highlights the main reasons for using the most popular contraceptives. Prevention of 
unintended pregnancy was the main reason cited for using condoms (72.7%, n=742 of 1,020, 
p<0.001), coitus interruptus (70.2%, n=118 of 168, p<0.001) and emergency contraception (75.3%, 
n=61 of 81, p<0.001). Delaying pregnancy rather than stopping pregnancy was cited more by 
students using the COCP (70.5%, n=514 of 729, p<0.001). ‘STI Prevention’ was given as a reason for 
using emergency contraception by 59.3% (n=48 of 81, p<0.001). Amongst those who relied on coitus 
interruptus, 40.5% (n=68 of 168, p<0.02) of them believed it offered STI protection. 
 
Personal monies were used by 70% (n=1,288 of 1,823) of students to finance their contraception, 
with only 11.8% (n=217 of 1,823) using a medical card. Gender influenced how students funded 
their contraception and their annual contraception costs. Male students were statistically more 
likely to pay for contraception using personal finances (89.1%, n=425 of 477 versus 63.8%, n=859 of 
1,346, p<0.001) but were also more likely to receive financial support from their partners (6.3%, 
n=30 of 477 versus 4.5%, n=60 of 1,346, p<0.001). Female students were more likely to receive 
parental support in paying for their contraception (12.6%, n=170 of 1,346 versus 0.8%, n=4 of 477, 
p<0.001). Statistically males were more likely to spend under €50 annually (47.6%, n=182 of 382, 
p<0.001) and female students were more likely to spend over €100 on contraception (41.2%, n=470 
of 1,141, p<0.001). 
 
 
Questions regarding whether students would change contraceptive if cost was removed, as well as 
selecting their preferred contraceptive were included in the survey. Of the 1,149 sexually active 
females who responded to the question, 34.3% (n=394) would definitely change and 21.8% (n=250) 
would consider changing. Older students were less likely to change contraception with 53.3% 
(n=121 of 227, p<0.001) not changing. A third of those aged 18-24 would definitely change (36.2%, 
n=331 of 913, p<0.001) while a further 22.6% (n=207 of 913, p<0.001) would consider changing. The 
type of contraceptive students would choose is highlighted in Table 4.  
 
 












Contraception students would change to  




COCP (n=723)  18 (1.2%) 214 (14%) 107 (7%) 61 (4%) 5 (0.3%) 30 (2%) 24 (1.6%) 
134 
(18.5%) 
POP (n=108) 6 (5.6%)  16 (14.8%) 12 (11.1%) 5 (4.6%) 0 (0%) 1 (0.9%) 24 (1.6%) 26 (24.1%) 
Condoms (n=1003) 151 (15.1%) 13 (1.3%) 141 (14.1%) 71 (7.1%) 38 (3.8%) 2 (0.2%) 19 (1.9%) 22 (2.2%) 
167 
(16.7%) 
Copper Coil (n=29) 2 (6.9%) 1 (3.4%) 2 (6.9%)  0 (0%) 0 (0%) 1 (3.4%) 0 (0%) 2 (6.9%) 
IUS (n=58) 0 (0%) 0 (0%) 1 (1.7%) 0 (0%)  0 (0%) 1 (1.7%) 0(0%) 6 (10.3%) 
Implanon (n=121) 8 (6.6%) 2 (2.5%)  6 (5%) 5 (4.1%) 0 (0%) 1 (0.8%) 0 (0%) 14 (11.6%) 
Depo (n=12) 0 (0%) 1 (8.3%) 0 (%) 2 (16.7%) 2 (16.7%)  0 (0%) 0 (%) 2 (16.7%) 
Coitus Interruptus 
(n=164) 
19 (11.6%) 2 (1.2%) 20 (12.2%) 21 (12.8%) 5 (3%) 0 (0%) 2 (1.2%) 2 (1.2%) 35 (21.5%) 
Emergency 
Contraception (n=81) 
15 (18.5%) 0 (0%) 14 (17.3%) 9 (11.1%) 3 (3.7%) 0 (0%) 1 (1.2%) 1 (1.2%) 16 (19.8%) 
Cyclical Method (n=41) 6 (14.6%) 3 (7.3%) 6 (14.6%) 2 (4.9%) 2 (4.9%) 0 (0%) 1 (2.4%) 2 (4.9%) 8 (19.5%) 
No Contraception 
(n=78) 
16 (20.5%) 0 (0%) 12 (15.4%) 6 (7.7%) 2 (2.6%) 0 (0%) 1 (1.3%) 0 (0%) 8 (10.3%) 
Discussion 
 
This study was one of the largest studies to date examining contraceptive use among Irish university 
students, including the factors influencing their contraceptive choices. Consistent with other studies 
of university students15, 18, 19, it shows that Irish students rely on either user-dependent or unreliable 
contraceptive methods. Prevention of pregnancy was the main reason for contraception use 
followed by STI protection, similar to other studies7.  
 
Consistent with Irish7 and international studies5, 15, 19, condoms and the COCP remain popular. UCC 
students’ condom usage was lower, at 55.4%, compared to Lally et al’s rate of 89%7.  Irish students 
are no different to international students; approximately half of Finnish female students use the 
COCP15 and 10% of Italian medical students use coitus interruptus as contraception19. In our study 
coitus interruptus was used by 9.1% of students. Misinformation among students remains a barrier 
to effective contraception use, especially IUDs(5, 20). In our study, 40.5% of those using coitus 
interruptus, and 59.3% of those using emergency contraception falsely believed it offered STI 
protection. Similar misconceptions were highlighted by Lally et al in 20157. This demonstrates, that 
despite several targeted public health campaigns misinformation on contraception and STI 
prevention still persists. The use of LARCs has not been shown to adversely impact students condom 
use versus other contraceptives for STI protection, overall dual-method contraception use remains 
low among young women21.  
 
In our study, 34.3% of sexually active female students would definitely change contraception if the 
cost was removed, evidencing that cost is a barrier. Amongst 18-24 year olds, 61.8% would either 
definitely change or consider changing. It was within this age group that Gyllenburg et al 
demonstrated an unmet need for contraception14 and, it is this cohort, that has the highest risk of 
an unplanned pregnancy in Ireland1. Even with subsidised student health services, the upfront cost 
of a Mirena® was €214 (€20 consultation fee22, €70 insertion fee22 and €124 Mirena® with the Drugs 
Payment Scheme23). It is female students who are most vulnerable to these costs and who are more 
likely to use effective contraception when the cost was reduced13, 18. Female UCC students also had 
a higher financial burden associated with contraception, being significantly more likely to spend 
over €100 annually on contraception. With the introduction of terminations in Ireland, the cost of 
accessing contraception has come to the fore. The Citizen’s Assembly raised their concerns 
regarding the prohibitive effect of cost in accessing contraception3. The previous Irish Health 
Minister, Mr Simon Harris, promised free contraception in 202124, however this did not materialise 
in Budget 202125.   
 
One of our study’s strengths is its sample size; it is one of the largest studies of Irish university 
students in recent times. However, its broadness, including students from various academic areas 
and levels of study, means it is not specific to a particular cohort within the University. Our study is 
one of the first examining university students as an individual population, and it is one of the most 
recent contraceptive studies after the introduction of abortion in Ireland.  
 
The limitations of our study include its predominately female population. Other factors influencing 
contraception choices such as previous sexual health education, were not examined within this 
study. The definition of ‘sexually active’ was not specifically defined within the questionnaire and 
may have been misinterpreted by students. Our questionnaire also assumed that students had some 
basic knowledge of contraceptives and their indications. To reduce the effect of previous sexual 
education, where possible, colloquial terms were used (e.g. ‘the bar’), and questions were phrased 
in everyday language.   
 
Students often use unreliable and user-dependent contraceptive methods to protect themselves 
against STIs and pregnancy. With prevention of unplanned pregnancies remaining a public health 
concern in Ireland3, removing the cost associated with LARCs may help to increase their uptake 
amongst students. The Government’s delay in providing free contraception means financial barriers 
still exist in Ireland today limiting access to effective contraception.  
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